Front Row Advisors’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.4K | Hold |
|
|||||
|
2025
Q1 | $36.6K | Hold |
|
|||||
|
2024
Q4 | $34.3K | Hold |
|
|||||
|
2024
Q3 | $40.4K | Hold |
|
|||||
|
2024
Q2 | $32.4K | Hold |
|
|||||
|
2024
Q1 | $27.1K | Hold |
|
|||||
|
2023
Q4 | $26.3K | Hold |
|
|||||
|
2023
Q3 | $21.3K | Hold |
|
|||||
|
2023
Q2 | $24K | Hold |
|
|||||
|
2023
Q1 | $32K | Hold |
|
|||||
|
2022
Q4 | $24K | Hold |
|
|||||
|
2022
Q3 | $20K | Hold |
|
|||||
|
2022
Q2 | $28K | Hold |
|
|||||
|
2022
Q1 | $31K | Buy |
|